Canada Life’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.8M Sell
382,894
-7,461
-2% -$615K 0.06% 281
2025
Q4
$33.3M Buy
390,355
+20,957
+6% +$1.72M 0.06% 257
2025
Q3
$28.5M Sell
369,398
-175,037
-32% -$13.7M 0.04% 347
2025
Q2
$42.6M Buy
544,435
+5,919
+1% +$441K 0.07% 256
2025
Q1
$39.1M Sell
538,516
-137,272
-20% -$9.83M 0.07% 258
2024
Q4
$50M Sell
675,788
-40,922
-6% -$2.86M 0.09% 206
2024
Q3
$47.3M Buy
716,710
+27,583
+4% +$2M 0.08% 224
2024
Q2
$63.7M Buy
689,127
+54,185
+9% +$4.8M 0.12% 156
2024
Q1
$60.7M Sell
634,942
-9,136
-1% -$767K 0.12% 160
2023
Q4
$48.9M Buy
644,078
+3,161
+0.5% +$220K 0.11% 190
2023
Q3
$44.4M Buy
640,917
+131,754
+26% +$10.6M 0.11% 187
2023
Q2
$48.3M Sell
509,163
-129,566
-20% -$11.3M 0.11% 176
2023
Q1
$52.8M Buy
638,729
+15,901
+3% +$1.25M 0.13% 163
2022
Q4
$46.7M Buy
622,828
+111,853
+22% +$8.62M 0.12% 180
2022
Q3
$42.2M Sell
510,975
-18,236
-3% -$1.75M 0.12% 174
2022
Q2
$50.4M Sell
529,211
-79,284
-13% -$8.21M 0.13% 157
2022
Q1
$75.5M Buy
608,495
+2,069
+0.3% +$232K 0.16% 126
2021
Q4
$78.3M Sell
606,426
-89,863
-13% -$10.5M 0.16% 122
2021
Q3
$79.3M Buy
696,289
+17,883
+3% +$2.04M 0.18% 103
2021
Q2
$70.2M Sell
678,406
-191,942
-22% -$18.1M 0.16% 132
2021
Q1
$72.3M Sell
870,348
-75,481
-8% -$6.38M 0.18% 123
2020
Q4
$86.1M Sell
945,829
-130,003
-12% -$10.8M 0.16% 137
2020
Q3
$85.9M Sell
1,075,832
-28,869
-3% -$2.25M 0.19% 123
2020
Q2
$76M Buy
1,104,701
+5,159
+0.5% +$367K 0.17% 132
2020
Q1
$69.8M Buy
1,099,542
+24,882
+2% +$1.79M 0.19% 121
2019
Q4
$82.9M Buy
1,074,660
+234,072
+28% +$18.3M 0.18% 126
2019
Q3
$61.6M Buy
840,588
+8,772
+1% +$616K 0.15% 161
2019
Q2
$51.2M Buy
831,816
+354,141
+74% +$21.4M 0.12% 196
2019
Q1
$30.4M Buy
477,675
+95,853
+25% +$5.47M 0.08% 241
2018
Q4
$18.6M Sell
381,822
-308,109
-45% -$15.6M 0.05% 320
2018
Q3
$40.1M Sell
689,931
-70,236
-9% -$3.44M 0.1% 218
2018
Q2
$36.9M Buy
760,167
+303,084
+66% +$14.1M 0.09% 238
2018
Q1
$21.3M Sell
457,083
-166,020
-27% -$7.21M 0.05% 330
2017
Q4
$23.4M Buy
623,103
+7,851
+1% +$288K 0.06% 321
2017
Q3
$22.3M Buy
615,252
+13,677
+2% +$522K 0.06% 327
2017
Q2
$23.7M Sell
601,575
-143,274
-19% -$5.23M 0.06% 301
2017
Q1
$23.4M Buy
744,849
+53,646
+8% +$1.68M 0.06% 294
2016
Q4
$21.7M Buy
691,203
+231,684
+50% +$7.51M 0.06% 301
2016
Q3
$18.4M Buy
459,519
+8,793
+2% +$331K 0.05% 337
2016
Q2
$15M Buy
450,726
+41,490
+10% +$1.42M 0.05% 374
2016
Q1
$12M Buy
409,236
+43,878
+12% +$1.21M 0.04% 367
2015
Q4
$9.63M Sell
365,358
-68,772
-16% -$1.79M 0.04% 403
2015
Q3
$10.3M Sell
434,130
-57,048
-12% -$1.38M 0.04% 379
2015
Q2
$11.6M Sell
491,178
-34,002
-6% -$767K 0.04% 391
2015
Q1
$12.4M Buy
525,180
+101,364
+24% +$2.27M 0.04% 388
2014
Q4
$8.97M Sell
423,816
-620,586
-59% -$12.5M 0.03% 450
2014
Q3
$17.9M Sell
1,044,402
-391,290
-27% -$6.18M 0.06% 321
2014
Q2
$20.8M Sell
1,435,692
-113,826
-7% -$1.54M 0.07% 292
2014
Q1
$18.7M Sell
1,549,518
-283,740
-15% -$3.27M 0.07% 303
2013
Q4
$20.2M Buy
1,833,258
+666,744
+57% +$7.52M 0.07% 279
2013
Q3
$13.4M Buy
1,166,514
+1,163,754
+42,165% +$13.6M 0.05% 327
2013
Q2
$31K Buy
+2,760
New +$32.7K ﹤0.01% 745

Other funds holding EW

Canada Life's EW Position: Q1 2026 in Review

Canada Life reduced its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, selling an estimated $615K and leaving 382,894 shares worth $30.8M. The position accounts for 0.06% of the portfolio, ranked #281.

Canada Life first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.1M in Q4 2020. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Canada Life held 382,894 shares of Edwards Lifesciences worth $30.8M as of Q1 2026.
  • Canada Life sold 7,461 Edwards Lifesciences shares in Q1 2026, an estimated $615K.
  • Edwards Lifesciences made up 0.06% of Canada Life's portfolio in Q1 2026, its #281 holding.
  • Canada Life first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Edwards Lifesciences position peaked at $86.1M in Q4 2020.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.